Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Study aims to clarify expression patterns of CD24 in NSCLC

Study aims to clarify expression patterns of CD24 in NSCLC

Milk consumption does not cause renal cell cancer

Milk consumption does not cause renal cell cancer

Genomic Health reports 22% revenue growth, 58% decrease in net loss for first-quarter 2010

Genomic Health reports 22% revenue growth, 58% decrease in net loss for first-quarter 2010

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Update on CEL-SCI's Phase III clinical trial of Multikine

Update on CEL-SCI's Phase III clinical trial of Multikine

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Celsion reports $4.6 million net loss from operations for first-quarter 2010

Celsion reports $4.6 million net loss from operations for first-quarter 2010

New classification of depressive subtypes of depression proposed

New classification of depressive subtypes of depression proposed

PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast cancer diagnosis

PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast cancer diagnosis

FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer

FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer

Health outcomes explored at DDW 2010

Health outcomes explored at DDW 2010

Endo Pharmaceuticals reports 9% increase in first-quarter 2010 revenues

Endo Pharmaceuticals reports 9% increase in first-quarter 2010 revenues

TenX Biopharma signs Clinical Trial Agreement with NCI

TenX Biopharma signs Clinical Trial Agreement with NCI

Immunogen reports a net loss of $12.1 million in third quarter 2010

Immunogen reports a net loss of $12.1 million in third quarter 2010

AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010

AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010

Three new biomarkers for ductal carcinoma in situ found

Three new biomarkers for ductal carcinoma in situ found

SBRT shows promise in treatment of lung, liver and spinal tumors: Clinical experts

SBRT shows promise in treatment of lung, liver and spinal tumors: Clinical experts

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.